Just reported
From GE HealthCare Technologies's results release of 2026년 10월 28일; its quarterly report has since been filed.
Actual
US$5.51B
+7.2% y/y
+4.1% q/q
Guided
—
No guide given
Actual
US$1.36
+39% y/y
+9.7% q/q
Guided
—
No guide given
Actual
US$805M
+23% y/y
+8.9% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
매출 비중은 nine months ended September 30, 2026 기준 추정치이며, 제출된 보고서의 수치가 아닙니다.
Computed tomography scanners
Scanners use X-rays to create cross-sectional and three-dimensional images that can help clinicians find problems such as tumors, blocked blood vessels, or fractures.
Magnetic resonance scanners
Scanners use magnetic fields to create detailed images of internal body structures, including the brain, heart, and muscles.
Ultrasound systems
Systems use sound waves to create images for diagnosis and monitoring, including during pregnancy, heart examinations, and procedures.
X-ray systems
Fixed, portable, and moving-image X-ray equipment helps clinicians examine bones, lungs, and other parts of the body.
Patient monitors and electrocardiogram devices
Devices measure and display signs such as heart rhythm, blood pressure, and oxygen levels so care teams can track patients.
Contrast agents and radiopharmaceuticals
These medicines are given before or during scans to make certain tissues or biological activity easier to see in images.
GE HealthCare makes scanners that create images of the body using X-rays, magnetic fields, or sound waves, along with equipment used to guide procedures and monitor patients. It also sells contrast agents and radioactive imaging drugs that help clinicians interpret scans, and provides equipment maintenance, software, and cloud services. Its software includes tools that use artificial intelligence (AI) to help with image analysis and clinical workflows.
GE HealthCare Technologies Inc.이(가) 미국 증권거래위원회(SEC)에 직접 제출한 공시로 만들었습니다. 수치는 보고된 그대로이며, 주당 이력은 오늘의 주식 수 기준으로 재계산했습니다. 이것은 사업을 설명하는 자료입니다. 투자 자문이 아니며 어떤 매수나 매도도 권유하지 않습니다.
The themes GE HealthCare Technologies is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
US$82.63-1.2%11월 11일 종가
2026년 9월 30일까지의 수치 (2026년 10월 28일 제출 10-Q 기준)
GE HealthCare sells medical imaging scanners and ultrasound systems to hospitals and health systems, plus diagnostic imaging drugs.
Grade A
주가 아래 띠는 각 날짜의 등급으로, 그 시점까지 공개된 자료만으로 산출했습니다.
GE HealthCare Technologies Inc.의 등급 이력 11개 분기 중 2개를 표시하고 있습니다. 나머지 9개는 2024년 2월까지 거슬러 올라갑니다.